Sort   by:  
 Page size 
UnknownThe early phase of the COVID-19 epidemic in Lombardy, Italy.
Not available
S-EPMC8605863 | biostudies-literature
UnknownGRP-3 and KAPP, encoding interactors of WAK1, negatively affect defense responses induced by oligogalacturonides and local response to wounding.
Not available
S-EPMC4783359 | biostudies-literature
UnknownReal-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study.
Not available
S-EPMC12609796 | biostudies-literature
UnknownEfficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review.
Not available
S-EPMC10178294 | biostudies-literature
UnknownREXO2 is an oligoribonuclease active in human mitochondria.
Not available
S-EPMC3669425 | biostudies-literature
UnknownFrom Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis.
Not available
S-EPMC7461566 | biostudies-literature
UnknownBronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report.
Not available
S-EPMC11526547 | biostudies-literature
UnknownEfficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis.
Not available
S-EPMC6199731 | biostudies-literature
UnknownHeterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis.
Not available
S-EPMC10276411 | biostudies-literature
UnknownNeutrophil elastase in bronchiectasis.
Not available
S-EPMC5735855 | biostudies-literature
Sort   by:  
 Page size